Wearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows

Author:

Lin Shuyu12ORCID,Cheng Xuanbing123ORCID,Zhu Jialun123,Wang Bo12ORCID,Jelinek David45,Zhao Yichao123ORCID,Wu Tsung-Yu123ORCID,Horrillo Abraham4ORCID,Tan Jiawei123ORCID,Yeung Justin13,Yan Wenzhong6ORCID,Forman Sarah14,Coller Hilary A.478ORCID,Milla Carlos9ORCID,Emaminejad Sam1210ORCID

Affiliation:

1. Interconnected and Integrated Bioelectronics Lab (I2BL), University of California, Los Angeles, Los Angeles, CA, USA.

2. Department of Electrical and Computer Engineering, University of California, Los Angeles, Los Angeles, CA, USA.

3. Department of Materials Science and Engineering, University of California, Los Angeles, Los Angeles, CA, USA.

4. Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, USA.

5. Weintraub Center for Reconstructive Biotechnology, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.

6. Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, Los Angeles, CA, USA.

7. Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

8. Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA.

9. The Stanford Cystic Fibrosis Center, Center for Excellence in Pulmonary Biology, Stanford School of Medicine, Stanford, CA, USA.

10. Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.

Abstract

Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic windows. Nevertheless, standard methods are imprecise and involve invasive/resource-intensive procedures with long turnaround times. Overcoming these limitations, we present a microneedle-based electrochemical aptamer biosensing patch (μNEAB-patch) that minimally invasively probes the interstitial fluid (ISF) and renders correlated, continuous, and real-time measurements of the circulating drugs’ pharmacokinetics. The μNEAB-patch is created following an introduced low-cost fabrication scheme, which transforms a shortened clinical-grade needle into a high-quality gold nanoparticle-based substrate for robust aptamer immobilization and efficient electrochemical signal retrieval. This enables the reliable in vivo detection of a wide library of ISF analytes—especially those with nonexistent natural recognition elements. Accordingly, we developed μNEABs targeting various drugs, including antibiotics with narrow therapeutic windows (tobramycin and vancomycin). Through in vivo animal studies, we demonstrated the strong correlation between the ISF/circulating drug levels and the device’s potential clinical use for timely prediction of total drug exposure.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3